Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species. [PDF]
Dembele L +10 more
europepmc +1 more source
Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer. [PDF]
Xie X, Chen Q, Guo C, Zeng J, He Q.
europepmc +1 more source
Single-cell transcriptional changes of artemisinin-sensitive K13<sup>C580</sup> and artemisinin-resistant K13<sup>580Y</sup> <i>Plasmodium falciparum</i> upon dihydroartemisinin exposure. [PDF]
Connelly SV +10 more
europepmc +1 more source
Pharmacokinetics and Toxicity Assessment of Artesunate and Its Metabolite, Dihydroartemisinin, in NOD Scid Gamma Mice. [PDF]
Agrawal P +4 more
europepmc +1 more source
Ligand decorated nanostructure carrier systems for targeted delivery of antimalarials. [PDF]
Singh K +8 more
europepmc +1 more source
Mapping the intellectual landscape of malaria drug repurposing: a systematic analysis of the 51 most cited studies. [PDF]
Tizhe DT +7 more
europepmc +1 more source
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway. [PDF]
Liu Y +5 more
europepmc +1 more source
Socio-demographic characteristics and parasite density patterns of Plasmodium knowlesi Malaria in Aceh, Indonesia: insights from hospital-based data. [PDF]
Maulana T +5 more
europepmc +1 more source
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated <i>Plasmodium falciparum</i> malaria in Ghana, 2023. [PDF]
Abuaku B +10 more
europepmc +1 more source
Dihydroartemisinin attenuates pemphigus vulgaris by regulating Dsg3 and the TLR9/NF-κB pathway. [PDF]
Cui Y +5 more
europepmc +1 more source

